Recently, Goldman Sachs Group, Inc. (NYSE: GS) announced it plans to create a private equity fund that will buy stakes in hedge funds. That could be interesting because investors reap profits based on the management/performance fees earned by the fund manager rather than the fund's performance itself. But because any hedge fund's growth is tied to its performance, these investments likely amount to bets on the ability of certain hedge funds to earn strong returns. Fortress Investment Group, LLC (NYSE: FIG), the first hedge fund to offer shares of itself in the United States, has performed terribly since its IPO.
Part of the problem with investing in a hedge fund manager is that so much of the money is paid out as bonuses to the managers that serving as a passive investor may not be as lucrative as it seems.
Today's Wall Street Journal takes a look (subscription required) at another popular way to invest in hedge funds: funds of funds.
The problem with funds of funds is that it's a lot like paying a broker a 5% commission to find a great broker whom you can pay 5% to sell your house: It adds in a layer of costs, and it's very difficult to produce the performance to overcome the disadvantage created by the huge fees.
Still, these funds of funds are showing rapid growth but, long-term, I would be willing to bet that these funds will underperform a passively-managed index. Fees always matter.
Last updated: February 13, 2012: 04:41 PM
Hot Stocks
DailyFinance Headlines
- 5 Things to Watch This Week: Cars, Games, Hearts, and a Lot of Z's
- 3 Keys to a Great Balance Transfer Card (and 1 Card That Offers Them)
- Is It Already 'The End' for E-Book Readers?
- Retail Stocks Are for Suckers: Why Their Rally Won't Last
- Suddenly, Amazon Doesn't Love Its Moms Anymore
Benzinga Headlines
- Military Budget Cuts Hit These Contractors
- Earnings Preview: Tesla Hoping to Retain its Drive
- Airlines the Latest to Suffer Euro Crisis Blues
- Internet-Hungry Consumers Force Vodafone to Consider a C&W Offer
- Seven Japanese Stocks Up More Than 10% Year to Date
TheFlyOnTheWall.com Headlines
- Ultra Clean sees Q1 EPS 15c-18c vs. consensus 9c
- Health Management reports Q4 same hospital revenue up 5% to $1.42M
- Ultra Clean Q4 EPS included a 28c tax benefit
- Ultra Clean reports Q4 EPS 34c vs. consensus 3c
- Health Management reports Q4 EPS 26c vs. consensus 20c
BioHealth Investor Headlines
- Can Human Genome Really Double Its Stock Price? (HGSI)
- Alimera Implosion Analysis, What Is Next (ALIM, PSDV)
- Implosion Analysis For Targacept… What Lies Ahead? (TRGT, AZN)
- Rare Analyst Calls With Huge Upside in Vical and VIVUS (VICL, VVUS, BMY)
- Top Biotechs With Upside Ahead of Earnings (GILD, AMLN, ARIA, INCY, JAZZ, DNDN, HGSI, ILMN, AMGN, CELG, BIIB, BMRN, LIFE, REGN, AMLN, CBST, ONXX, THRX, VPHM)
WalletPop Headlines
- 5 Things to Watch This Week: Cars, Games, Hearts, and a Lot of Z's
- 3 Keys to a Great Balance Transfer Card (and 1 Card That Offers Them)
- Is It Already 'The End' for E-Book Readers?
- Retail Stocks Are for Suckers: Why Their Rally Won't Last
- Suddenly, Amazon Doesn't Love Its Moms Anymore
My Portfolios
Track your stocks here!
Find out why more people track their portfolios on AOL Money & Finance then anywhere else.
BloggingStocks Partners
More from AOL Money & Finance
- Business News
- Stock Screener
- Stock Quotes
- Stock Charts
- Banking
- Identity Theft
- DJIA
- Debt Management
- Loans
- Auto Loan
- Mortgages
- Taxes
- Retirement
- Insurance
- Small Business
- Earnings
- Tech News
- Tax Forms
- Tax Deductions
- Tax Credit
- Tax Audit
- Tax Advice
- Stock Ticker
- Stock Brokers
- Resume Builder
- Pig Flu
- Online Tax Filing
- Madoff
- Investing For Retirement
- Income Tax
- Historical Stock Prices
- GOOG
- ETF Investing
- Deals
- DailyFinance
- Crude Oil Prices
- Credit Score Calculator
- Common Tax Filing Mistakes
- AMT
BioHealth Investor Headlines
- Can Human Genome Really Double Its Stock Price? (HGSI)
- Alimera Implosion Analysis, What Is Next (ALIM, PSDV)
- Implosion Analysis For Targacept… What Lies Ahead? (TRGT, AZN)
- Rare Analyst Calls With Huge Upside in Vical and VIVUS (VICL, VVUS, BMY)
- Top Biotechs With Upside Ahead of Earnings (GILD, AMLN, ARIA, INCY, JAZZ, DNDN, HGSI, ILMN, AMGN, CELG, BIIB, BMRN, LIFE, REGN, AMLN, CBST, ONXX, THRX, VPHM)
5-Hour Energy: A Success Equal Parts Caffeine, Chemistry and…
Suddenly, Amazon Doesn't Love Its Moms Anymore

